newsfilter
← Latest News
Business Wire·

ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions

Commemorating a quarter of a century with an exclusive 25% off lifelong subscription on Tru Niagen® ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a